Kronox Lab Sciences growth ratios

·ChemicalsChart ›
ProfitabilityGrowthCreditLiquidityWorking capitalDividend yieldDuPontCAGR
Per cent unless marked ×
Tap a line for its trendFY26Mar 2026FY25Mar 2025
+1.0%+11.5%
+3.5%+17.0%
+1.5%+17.4%
+9.3%+18.5%
+8.7%+18.9%
+29.0%+33.6%
+28.9%+35.9%
−26.4%+86.5%
Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

KRONOX₹194.73

Kronox Lab Sciences Limited

· Chemicals
₹ CrorePeersJAYAGROGNDMCCSRHHYPOLTDCHEMFABPRIMOPLASTIBLENGEMAROMASUDARCOLORMcap ₹723 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Revenue Growth—+11.5+1.0—
EBITDA Growth—+17.0+3.5—
EBIT Growth—+17.4+1.5—
Net Income Growth—+18.5+9.3—
EPS Growth—+18.9+8.7—
Total Assets Growth—+33.6+29.0—
Total Equity Growth—+35.9+28.9—
Cash from Operations Growth—+86.5-26.4—
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · StandaloneFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.